Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 22 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-11-12 HOFFMAN STEPHEN J Chief Executive Officer Purchase +30,000 $2.01 $60K 31,967
2018-11-09 HOFFMAN STEPHEN J Chief Executive Officer Purchase +1,967 $1.95 $4K 1,967
2018-10-26 Dugel Pravin Director Grant or award · Stock Option (Right to Buy) +2,500 2,500
2018-09-24 Castelein Caley Director Other acquisition +268,987 279,907
2018-09-24 Castelein Caley Director Returned to the company −1,603,526 0
2018-08-20 Novartis Bioventures Ltd 10% owner Sale −5,300 $3.90 $21K 5,800,250
2018-06-28 ORBIMED ADVISORS LLC Director Purchase +777,500 $3.85 $3.0M 5,193,946
2018-06-28 Khuong Chau Quang Director Purchase +777,500 $3.85 $3.0M 5,193,946
2018-06-28 Satter Muneer A Director Purchase +1,818,182 $3.85 $7.0M 5,078,017
2018-06-20 Satter Muneer A Director Grant or award · Stock Option (Right to Buy) +21,400 21,400
2018-06-20 Dalal Anupam Director Grant or award · Stock Option (Right to Buy) +21,400 21,400
2017-03-15 Novartis Bioventures Ltd 10% owner Purchase +560,000 $5.00 $2.8M 5,805,550

Page 16 of 16 · 312 trades